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Monoclonal antibodies (mAb)  * to cell surface L3T4 and Lyt-2 molecules define 
two  broad  classes of T  cells (1,  2);  both  T  cell subsets are restricted by H-2 
molecules (3).  L3T4 ÷ Lyt-2- T  cells provide T  helper (Th) function and are 
restricted by H-2 class II (I-A, I-E) (Ia) molecules, both in terms of H-2 alloreac- 
tivity and recognition of non H-2 antigens in the context of self H-2 molecules. 
L3T4- Lyt-2  + T  cells exert cell-mediated lympholysis (CML) and are restricted 
by H-2  class  I  (H-2K,  H-2D)  molecules.  Whereas class  II-restricted Th  cells 
function independently of other T cells, it has been long argued that the function 
of cytotoxic lymphocytes (CTL) and their precursors requires interaction with 
Th cells (4-6). Although the mechanism of such T-T interaction is still debated, 
the  simplest  view  is  that  Th  cells  facilitate  CTL  differentiation through  the 
production of interleukin 2  (IL-2), a lymphokine known to control the growth 
of CTL  (7).  A  key question  is  whether Th  cells  play  an  obligatory  role  in 
controlling CTL  differentiation or  merely augment the growth of these cells 
after the induction phase. 
Recent evidence (8-10)  suggests that,  under certain circumstances, CTL or 
their precursors can differentiate without the requirement for exogenous help. 
Perhaps the first evidence supporting  this  notion came from the finding that 
depleting unprimed lymph node (LN) cells of la-restricted Lyt-1 + T  cells failed 
to impair lethal graft-vs-host disease (GVHD) directed to minor histocompatibility 
antigens in heavily irradiated mice (11,  12); purified Lyt-1- Lyt-2  + T  cells were 
as effective as unseparated T  cells at causing GVHD,  implying that help from 
Lyt-2- T  cells was not required in this situation.  Subsequently, several groups 
have reported the existence of Lyt-2  + T  cell clones that proliferate in response 
to antigen in vitro in the absence of exogenous IL-2 from Lyt-2- T  cells (8-10). 
The  notion  that,  under  certain  conditions,  Lyt-2  +  T  cells  can  respond  to 
antigen without the requirement for interaction with Lyt-2- T  cells implies that 
purified Lyt-2  + T cells should be capable of mounting primary mixed lymphocyte 
reaction (MLR) and CTL responses to alloantigens, especially to class I alloanti- 
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gens.  In this respect it has long been held that primary MLR with unseparated 
T  cells are  lower to class  I  differences than  to class  II  differences (13-15).  A 
notable exception is  that  C57BL/6  (B6) T  cells elicit high  MLR  to cells from 
strains such as B6.C-H-2  b"l (bm 1) (15,  16), which are identical to B6 except for 
slight (two to three amino acids) differences in the H-2K molecule (17). Recently 
(18,  19),  it has been reported that the response of B6 T  cells to bm 1 involves 
recognition of K bml molecules in the context of self class II molecules, implying 
that  the  response  of class  I-specific CTL  precursor cells  to bml  is  under  the 
control of class  II-specific Th  cells. Others have contested this conclusion and 
argue that B6 T  cells highly enriched for Lyt-2  + cells respond well to bml  (10). 
For rats, some workers have observed high primary MLR with purified OX-8 + 
cells (20) (OX-8 is the homologue of Lyt-2). Others contend that the response 
of OX-8 + cells in MLR reflects contamination with W2/25 Th cells (21). 
The main aim of the present work was to prepare highly purified populations 
of L3T4  + and  Lyt-2  + cells and determine which of these subsets participate in 
primary responses to allo class  I  vs.  class  II differences in  vitro.  In the case of 
Lyt-2  + cells, particular emphasis was placed on using T  cell proliferation (MLR) 
rather than CTL generation to quantitate the responses; MLR were demonstra- 
ble as early as day 2, well before CTL were detected. The results suggest that 
both T  cell subsets function independently, L3T4  ÷ T  cells accounting for anti- 
class  II  responses  and  Lyt-2  ÷  T  cells  for  class  I  responses.  In  particular,  no 
evidence was  found  that  the  response  of Lyt-2  +  T  cells  to  class  I  differences 
depended upon the presence of L3T4  ÷ T  cells. 
Materials and Methods 
Mice.  C57BL/6Kh (B6),  C57BL/10 (B10), B6.C-H-2  b"'  (bml),  B6.C-H-2  bin4 (bm4), 
B6.C-H-2  bin9  (bm9),  B6.C-H-2  bm~l  (bmll),  B6.C-H-2  bm~2  (bml2),  B10.BR,  B10.A, 
B 10.A(4R), B10.A(2R), B10.P, and CBA/Ca (CBA) mice were obtained from the breeding 
colony of the  Research  Institute  of Scripps Clinic.  B10.AQR  and B10.TL mice were 
kindly provided by Dr. Chella David (Mayo Clinic). 
Irradiation.  Cells  were exposed to 1,500 rad of irradiation from a  1STCs source (500 
rad/min) delivered by a Gamma cell 1000 irradiator (Atomic Energy of Canada, Ottawa, 
Canada). 
Media.  RPMI  1640  and  Hanks'  balanced salt solution (HBSS) were used.  For cell 
separation  and  purification,  medium  (usually  HBSS)  was  supplemented  with  5%  7- 
globulin-depleted horse serum  (Gibco Laboratories, Santa Clara,  CA) and  Hepes.  For 
MLR and CTL generation,  RPMI  1640 was  supplemented with  10%  fetal calf serum 
(FCS) (Irvine Scientific, Santa Ana, CA) or 0.5% fresh normal mouse serum (NMS),  5% 
NCTC 109, 2 mM glutamine, 5 x  10  -5 M 2-mercaptoethanol, and antibiotics. 
Monoclonal Antibodies.  The following mAb were used: hybridoma GK1.5 (anti-L3T4, 
rat IgG2b), ascites fluid (diluted 1:10 as stock solution) (2); hybridoma 3.168.8 (anti-Lyt- 
2, rat IgM), ascites fluid (22); hybridoma J lj (anti-Thy 1.2, rat IgM), ascites fluid (diluted 
1:10 as stock solution) (23); hybridoma 11-5.2 (anti-I-A  k, mouse IgG2b), ascites fluid (24); 
hybridoma BP107 (anti-I-A  b, mouse IgG2a), ascites fluid (25); hybridoma J1 ld (lytic for 
B cells but not mature T cells, rat IgM), culture supernatant (23); and hybridoma 20-8-4s 
(anti-KbD b, mouse IgG2a), protein A-purified ascites fluid (26).  With the exception of 
J1 ld, all hybridomas were grown in ascites form in (B6 ×  CBA)Fl mice preconditioned 
with  Pristane  (0.5  ml  intraperitoneally  1-2  wk  before), antilymphocyte serum  (M.  A. 
Bioproducts, Walkersville, M D) (50-100 #1 given 2-~ d before) and whole body irradiation 
(500-600 rad 4-6 h before). Cytotoxic titers of ascites fluid were in the range of 5 X 104 
to 5 ×  106. For J1 ld, culture supernatant from cells grown in vitro was used. Guinea pig 2070  IN  VITRO  RESPONSES  OF  PURIFIED T  CELL  SUBSETS 
serum absorbed with mouse spleen cells was used as a source of complement (C'). Guinea 
pig  serum  obtained  from  commercial  sources  gave  erratic  results  with  several  of the 
hybridomas, especially GK1.5; preparation of our own guinea pig serum generally gave 
the best results. 
Purification of Responder Cells  for MLR.  Cell suspensions of pooled axillary, inguinal, 
cervical and mesenteric LN were prepared  with tissue homogenizers. Semipurified pop- 
ulations of Lyt-2  + and L3T4  + cells were made in a  one-step procedure by treating LN 
cells with a  mixture of J1 ld plus anti-LBT4 mAb plus C' (for Lyt-2  ÷ cells) or J1 ld plus 
anti-Lyt-2 mAb plus C' (for L3T4  + ceils).  The concentrations of mAb used to treat the 
LN  ceils  were: J1 ld,  0.3  ml  of undiluted  culture  supernatant  per  5  x  107 cells; anti- 
L3T4, 0.1  ml of ascites  fluid (prediluted  t:10) per 5  x  107 ceils; anti-Lyt-2,  0.1  ml of 
ascites  fluid per 5  X  107 cells.  Cells were incubated at a  final concentration of 5  X  107 
cells/ml for 60 min at 37°C and washed three times before further use. 
Further purification of T  cell subsets was achieved by panning.  To prepare  purified 
Lyt-2  + cells, semipurified cells (LN pretreated with J1 ld, anti-L3T4, and C') were placed 
on 100 x  15 mm petri dishes coated with anti-Lyt-2  ÷ mAb. Dishes were coated with 5 ml 
ofa 1:50 dilution ofmAb in phosphate-buffered saline (PBS) for 1 h at room temperature. 
After pouring off the mAb solution, the plates were rinsed five times with PBS and once 
with HBSS plus 5% horse serum. Cell doses in the range of 107 to 2.5 X  107 viable cells 
per  plate  were poured  onto the  plates  in a  volume of 3.5  ml of HBSS plus  5%  horse 
serum. Cells were incubated on the dishes for 1 h at 4 o  C. Nonadherent cells were removed 
by very carefully washing the plates five times with medium. Adherent cells were eluted 
from the dishes by vigorous pipetting with a Pasteur pipette.  Fluorescence-activated cell 
sorter (FACS) analysis (see Table I) indicated that the eluted cells were not coated with 
antibody. 
Percoll Separation.  To  attempt  to  deplete  responder  cells  of IL-2-responsive cells, 
dense  cells  were  harvested  from  band  5  (1.09  density  interface)  of Percoll  gradients 
prepared according to the method of Ratcliffe and Julius (27). 
Cell Typing.  Antibody-mediated lysis in the presence of C' was measured in a one-step 
assay as described elsewhere (23). Cell viability was assessed by phase contrast microscopy. 
To stain cells for FACS analysis, aliquots of 106 cells in  ! 00 #1 of HBSS supplemented 
with 5% horse serum and 0.1% sodium azide were incubated at 4°C for 30 rain with 25 
#I of mAb (undiluted ascites fluid), washed three times, and then incubated for a further 
30 min at 4°C with  5 #g fluorescein isothiocyanate (FITC)-labeled mouse anti-rat  IgG 
(heavy and light chain specific) (Pel-Freez  Biologicals, Rogers, AR). After being washed 
three  times,  the  labeled  cells  were  analysed  on  a  FACS  IV  flow  cytometer  (Becton 
Dickinson Immunocytometry Systems, Mountain View, CA). 
Purification of Stimulator  Cells for MLR.  Spleen  cells  were  depleted  of T  cells  by 
incubation with anti-Thy-1 mAb (0.1 ml ofJ lj ascites fluid diluted  1:10 per 5 x  107 cells) 
plus C'. To deplete bml  spleen cells of Ia  ÷ cells, cells were cultured with anti-I-A  b mAb 
(0.05 ml of BP107 ascites fluid per  1.5  x  107 cells)  plus C'. In both situations the cells 
were incubated with mAb plus C' for 60 rain, washed thoroughly, exposed to 1,500 rad, 
and then used as stimulator cells. 
MLR.  Unless stated otherwise,  1-2 x  105 responder cells were cultured in flat-bottom 
microtiter plates with 5 x  105 irradiated (1,500 rad) spleen cells as stimulators in a volume 
of 200 #1. Cultures were pulsed with  1 #Ci [3H]thymidine ([3H]TdR) and harvested  18 h 
later. 
Generation of CTL.  2  X  10  6 B6 T  cells or B6 Lyt-2  ÷ cells were cultured with 5 x  106 
1,500 rad bml spleen cells in a volume of 2 ml in 24-well plates. After 4 d the cells pooled 
from several wells were washed and counted (only blast cells were counted); the number 
of cells recovered (>90% blasts) were equivalent to, or exceeded, the number of respond- 
ers initially plated,  cell  recoveries  being appreciably higher with  B6  Lyt-2  + than  B6 T 
cells. To measure CTL activity, varying numbers of responder cells were cultured for 3 
o  4  51  h at 37  C with fixed numbers (10) of  Cr-labeled target cells (spleen cells cultured for 
3 d  with concanavalin A, 5 #g/ml); target cells were labeled with  300 #Ci 5~Cr per 4  × 
10  ~ cells at 37°C for  1 h and  then washed  three times.  The percent 5ZCr release from SPRENT  AND  SCHAEFER  2071 
target cells was measured by standard techniques, taking release of isotope from detergent- 
treated cells as 100% release. 
Negative Selection.  LN cells were filtered from blood to thoracic duct lymph through 
irradiated H-2-different mice as described elsewhere (28). 
IL-2.  Recombinant human IL-2 (rIL-2)  was kindly provided by Cetus Corp., Emery- 
ville, CA. Supernatant of rat lymphoid cells stimulated in vitro with concanavalin  A (Con 
A SN) was generously made available by Dr. S. Webb of this institution;  the batch of Con 
A SN used had a high titer in terms of promoting growth of IL-2-dependent HT-2 cells. 
Results 
In testing the function of the two subsets oft  cells in MLR, it was considered 
essential to use highly purified populations of cells as responders. The approach 
used for cell purification is outlined below. 
Preparation  of Purified  T  Cell  Subsets.  Treatment  of normal  LN  cells  with 
J1 ld  (anti-B  cell)  mAb  plus  C'  yielded a  population  containing  98-100%  of 
Thy-1 + cells (Table I, group A); J 11 d has no detectable reactivity for peripheral 
T  cells (23). When tested by cytotoxicity or by FITC staining, the ratio of L3T4 + 
to Lyt-2  + T  cells in J1 ld-treated LN ranged from 1:1  (Table I, group A; Fig.  1) 
to  2:1,  depending  upon the strain  and age of the  cell donors.  When  LN cells 
were treated with a  mixture  of J1 ld, anti-L3T4  mAb, and C',  85-95%  of the 
surviving cells were positive for Lyt-2 (Table I, group B); virtually none of the 
cells were positive for  L3T4,  even by FITC  staining.  Cells treated with J1 ld, 
anti-L3T4  mAb and  C'  were further  purified by panning,  i.e.,  by placing the 
cells  on  anti-Lyt-2-coated  plastic  dishes  for  1  h  at  4°C,  washing  away  the 
nonadherent  cells,  and  then  eluting  the  adherent  cells by vigorous  pipetting 
(Materials and Methods). As assessed by both cytotoxicity and FITC staining, the 
cells obtained by this procedure were >99% Lyt-2  ÷ and contained no detectable 
L3T4 ÷ cells  (Table  I,  group  D;  Fig  1).  Cytotoxic testing  of five  consecutive 
batches of these cells gave mean cytotoxic indices of 99% with anti-Lyt-2  mAb 
and <1%  with anti-L3T4  mAb.  An analogous procedure was used to prepare 
L3T4 + cells.  LN cells surviving  treatment  with J1 ld,  anti-Lyt-2  mAb, and  C' 
contained  85-95%  L3T4 + cells and no detectable Lyt-2  ÷ cells (Table I, group 
C). Panning on anti-L3T4-coated dishes yielded a population containing ~ 100 % 
L3T4 + cells with no detectable Lyt-2  + cells (Table I, group E; Fig.  1). 
MLR  to  Full  H-2  Differences.  An  initial  experiment  with  B10  T  cells  as 
responders  is  shown  in  Table  II,  Exp.  1.  MLR were measured  on  day  3.  As 
expected, purified  B10 (H-2  b) T  cells (cells treated with J1 ld only) responded 
well to B10.BR (H-2  k) stimulators  and  gave relatively low background  counts 
with  syngeneic stimulators.  When  semipurified  L3T4  + cells (cells treated  with 
J1 ld,  anti-Lyt-2  mAb,  and  C'  but not  panned)  were  used as  responders,  the 
response to B10.BR decreased. With semipurified Lyt-2  ÷ cells as responders, by 
contrast, the response to B 10.BR increased. 
MLR to bml  vs.  bm12 Stimulators.  Similar  cell populations derived from B6 
LN were tested for their capacity to respond to bml  vs. bml 2 stimulators,  i.e., 
stimulators differing only at class I (bml) or class II (bml2) loci (Table II, Exp. 
2).  Whereas  B6  T  cells  responded  well  to  both  bml  and  bml2  stimulators, 
semipurified  L3T4 +  cells  showed  an  increased  response  to  bml2  but  gave 
virtually no response to bm 1. The reverse applied to semipurified  Lyt-2  ÷ cells. 2072  IN  VITRO  RESPONSES  OF  PURIFIED T  CELL  SUBSETS 
TABLE  I 
Surface Markers of Semipurified vs. Highly Purified Lyt-2  + and L3T4  + LN Cells 
Group  Pretreatment of B6 LN*  Assay for typing cells 
Percent of cells reactive 
with mAb: 
Anti-  Anti-  Anti- 
Thy-1.2  L3T4  Lyt-2 
A  J1 ld + C'  C'-mediated cytotoxicity*  99  45  51 
FITC staining~  98.5  47.4  50.1 
B  J l l d + anti-L3T4 + C'  C'-mediated cytotoxicity  98  0  89 
FITC staining  98.0  -0.7  93.5 
C  J1 ld + anti-Lyt-2 + C'  C'-mediated cytotoxicity  98  88  0 
FITC staining  96.6  92.7  -0.4 
D 
E 
j1 ld + anti-L3T4 + C', then  C'-mediated cytotoxicity  100  0  100 
panned on anti-Lyt-2-  FITC staining  99.8  -0.2  99.4 
coated plates 
j1 ld + anti-Lyt-2 + C', then  C'-mediated cytotoxicity  100  99  0 
panned on anti-L3T4-  F1TC staining  99.7  99.8  -0.1 
coated plates 
* Normal  B6 LN cells were treated in the presence  of C' with J1 ld mAb (group A), Jl ld + anti- 
L3T4 mAb (group B) or J1 ld + anti-Lyt-2 mAb (group C) for 60 rain at 37°C (see Materials and 
Methods  for details). After washing, aliquots of the group B and group C cells were placed on 
plastic dishes coated  with anti-Lyt-2 (group  D) or anti-L3T4 mAb (group  E) for 60 rain at 4°C. 
After gentle rinsing with medium to remove nonadherent cells, the adherent cells were eluted 
from the dishes by vigorous pipetting. 
* Dead cells were  first  removed by Ficoll separation.  The data are shown in terms of cytotoxic 
indices; background lysis  with cells treated with C' alone varied from 1 to 8%. Viability was assessed 
on >600 cells per sample. 
§ Cells were typed by incubating  cells with anti-Thy-1,  anti-L3T4, or anti-Lyt-2 mAb followed by an 
FITC anti-rat lg antiserum (Materials and Methods). Labeled cells were detected by FACS analysis. 
Background labeling  observed with FITC anti-rat Ig alone was 1.1% for group A, 7.5% for group 
B, 3.0% for group C, 1.7% for group D, and 1.4% for group E. The data are shown in terms of a 
staining index, i.e., [(percent staining experimental group -  percent staining with FITC anti-rat 
Ig) + (100 -  percent staining with FITC anti-rat Ig)] X 100. 
Here there was a  high response to bml  but a  low response to bm12. Exp.  3  of 
Table I1 shows the effects of using highly purified ("kill pan") B6 Lyt-2  + T  cells 
as  responders.  Three  points  are  evident.  First,  the  background  counts  with 
syngeneic stimulators were  almost  nonexistent. Second,  the  responses to  bml 
were  conspicuously high.  Third,  in contrast  to  the  use of semipurified Lyt-2  + 
cells (Exp.  2), there was virtually no response to bm 12.  F1 stimulators were used 
in  these  experiments to  minimize backstimulation (29).  To  further  minimize 
backstimulation, the  stimulators (Fl  or  homozygous) in several subsequent ex- 
periments (e.g., Tables III and IV and Figs. 2 and 3) were pretreated with anti- 
Thy-1 mAb plus C' to remove T  cells, a potential source of IL-2. In no case did 
the use of anti-Thy-l-treated  stimulators lower the response of purified Lyt-2  + 
cells.  In all  of the  experiments considered below,  purified Lyt-2  + and  L3T4 + 
cells  were  prepared  by  the  combination of  killing with  the  reciprocal  mAb 
followed by positive panning. For simplicity these purified cell populations will SPRENT  AND  SCHAEFER  2073 
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FIGURE  1.  FACS profile of purified B6 LN T  cells (A), Lyt-2  ÷ cells (B), and L3T4  ÷ cells (C) 
incubated with anti-L3T4, -Lyt-2,  or -Thy-l.2  mAb followed by FITC-labeled anti-rat Ig 
(aRig). See Table I footnotes and Materials and Methods for details, 
TABLE  II 
MLR by Semipurified vs. Highly Purified Lyt-2  ÷ T Cells: Response to bml vs. bm12 
Pretreatment of  No, of  [SH]TdR (Xl0  -5) incorporation 
Exp.  Responders  respond-  with stimulators (5 x  105)  *  No.  responders  ers 
B10  BI0.BR 
B10 T  J1 ld +  C'  2  ×  105  1.3 (0.5)  54.8 (0.8) 
B10 L3T4  +  Anti-Lyt-2 +  C'  2 ×  105  2.4 (0.2)  16.8 (3.6) 
B10 Lyt-2  ÷  Anti-L3T4 +  C'  2 ×  105  0.9 (0.5)  73.0 (3.5) 
B6  bml  bml2 
B6 T  Jl ld +  C'  1 ×  105  1.5 (0.5)  40.3 (6.2)  16.0 (2.5) 
B6 L3T4  +  Anti-Lyt-2 +  C'  1 x  105  4.1 (0.6)  4.6 (0.6)  26.8 (2.6) 
B6 Lyt-2  ÷  Anti-L3T4 +  C'  1 ×  105  0.7 (0.0)  79.4 (4.8)  4.4 (1.3) 
(B6 x  (B6 x 
B6  bml)Fl  bml2)Fl 
3  B6 Lyt-2  ÷  Anti-L3T4 +  C', then  1 ×  105  0.2 (0.1)  53.0 (5.5)  0.7 (0.3) 
panned on anti-Lyt-2-  2 ×  105  0.7 (0.3)  105.8 (2.5)  0.9 (0.2) 
coated plates 
* Data  are  shown  as  the  mean  of  triplicate  cultures;  SD  are  shown  in  parentheses.  [3H]TdR 
incorporation measured on day 3 of culture. Cells cultured in 10% FCS. 2074  IN  VITRO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
be  referred  to  as  Lyt-2  ÷  and  L3T4 ÷  cells.  It  will  be  noted  below  that  the 
background  counts  observed  when  Lyt-2  ÷  cells  were  cultured  with  syngeneic 
stimulators were almost undetectable. With L3T4 + cells, by contrast, background 
counts  (auto-MLR)  were often  very high, particularly when  cells were cultured 
in FCS. Many experiments  with L3T4 + cells had to be discarded because of high 
background  counts, and only the optimal experiments are presented. 
A  time course of the response of B6 Lyt-2  + and L3T4 + cells in MLR  is shown 
in Fig. 2; cells were cultured either in 0.5%  NMS (Fig. 2, top) or  10%  FCS (Fig. 
2, bottom).  In  the  case  of B6  L3T4 +  ceils,  it can  be  seen  that  the  response  to 
bml 2  rose progressively and  reached  maximum  values on day 6; a  similar time 
course  was  observed  with  responses  to  (B6  X  CBA/Ca)F1  stimulators,  i.e.,  to a 
full H-2  difference.  Responses of L3T4 + cells to bml  were almost nonexistent. 
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FIGURE 2.  Time course of MLR of purified B6 LN L3T4 + and Lyt-2  + cells stimulated against 
class I (bml) vs. class II (bml2) differences or against a whole H-2 difference (CBA, H-2k); 1 
X 105 responder cells. Cells were cultured in either 10% FCS or 0.5% NMS. Stimulators were 
pretreated with anti-Thy-1 mAb + C'. SPRENT  AND  SCHAEFER  2075 
With B6  Lyt-2  + responders, the responses to bml  and (B6  x  CBA)F~  reached 
peak values on day 4 (FCS) or day 4-5 (NMS) and then declined precipitously. 
Responses to bm 12 were virtually undetectable. 
MLR  to  Other Mutant Class I  Differences.  As shown in Table III, B6  Lyt-2  + 
cells gave high responses not only to bml  but also to bin4  and bml 1.  Much 
lower  responses  were  detected  against  bm9.  High  responses  were  observed 
against various full H-2 differences, including B10.BR (Table III), B10.P (tt-2  p) 
and B10.D2 (H-2  ~) (data not sbown). 
MLR to AUelic Class I Differences.  In Exp.  1 of Table IV, B10.A T  cells and 
BI0.A Lyt-2  + cells  were compared for their capacity to respond to various H- 
2K/D allelic differences (D  k,  D b,  Kq,  K').  It is evident that B10.A  Lyt-2  + cells 
gave approximately twofold higher responses to these differences than B 10.A T 
cells in three of the four combinations tested. 
Exp. 2 of Table IV demonstrates that B 10.A(4R) Lyt-2  ÷ cells failed to respond 
to an ailelic class  II difference, i.e., to I-E  k molecules expressed by B10.A(2R) 
cells. This finding paralled the unresponsiveness of B6 Lyt-2  + cells to the class II 
mutant, bm 12 (see above). 
MLR  to  Class I  Differences Across  an Ia Barrier.  The finding that Lyt-2  + T 
cells responded well to a full H-2 difference yet failed to respond to stimulators 
differing only at class II loci (Tables III, IV) implied that the response of Lyt-2  + 
T  cells to class I differences did not require Ia compatibility with the stimulators. 
The experiment shown in Exp.  3 of Table IV provides direct support for this 
notion. Here it can be seen that CBA (Ia  k) Lyt-2  ÷ cells negatively selected against 
B6 (Ia  b) H-2 determinants in vivo gave no response to B6 in vitro but responded 
well to bml. (See Table IV footnote for details of the procedure for negative 
selection.) 
MLR in  the Presence of Added IL-2.  The effects of adding rIL-2 (100  U/ml) 
to MLR elicited by Lyt-2  ÷ and L3T4  ÷ cells is shown in Fig. 3. B6 L3T4  ÷ and B6 
Lyt-2  +  cells  were  stimulated  against  bml2  and  bmI  cells,  respectively;  for 
convenience the data are plotted on a log scale. In the case of L3T4  + cells,  it is 
evident the response to bml2 stimulators increased exponentially from days 2 
to 6. Addition of IL-2 had no effect on this response. The MLR of Lyt-2  + cells 
TABLE  III 
Response of Purified Lyt-2 ÷ T Cells to Various Mutant Class I H-2 Differences 
Stimulators  [3H]TdR incorporation (X 10-3) * 
Responders  (anti-Thy° 1-  H-2 haplotype of  stimulators*  No. of responders: 
treated)  1 ×  105  2 x  105 
B6 Lyt-2  +  B6  bbbb  0.2 (0.0)*  0.3 (0.1) 
bml  bmlbbb  155.3 (23.11)  336.5 (16.2) 
bm4  bm4bbb  57.3 (8.4)  120.3 (12.3) 
bm9  bm9bbb  11.8 (1.1)  33.5 (2.5) 
bml 1  bmllbbb  179.3 (4.7)  275.8 (28.3) 
bml2  bbm12bb  0.4 (0.1)  2.6 (1.8) 
B10.BR  kkkk  79.3 (14.7)  257.4 (22.3) 
* K, l-A, I-E, D. 
* Mean of triplicate cultures (SD). Responses measured on day 4; cells cultured in 10%  FCS. 2076  IN  VITRO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
TABLE  IV 
Response of Purified Lyt-2  + T cells to Various AUelic Class 11-1-2 Differences 
Exp. 
No. 
Stimulators  H-2 hap- 
Responders  (anti-Thy-1-  lotype of  Stimulus 
(2 ×  105)  treated)  stimula- 
tors* 
[SH]TdR in- 
corporation 
(×10 -3  ) with 
stimulators* 
1  BI0.A T  B10.A  kkkd  None  1.1 (0.2) 
B6  bbbb  H-2  b  86.6 (5.1) 
B10.BR  kkkk  D  k  28.6 (2.0) 
B10.A(4R)  kkbb  D  b  12.9 (1.7) 
B10.AQR  qkkd  K  q  24.4 (3.0) 
B10.TL  skkd  K'  16.5 (3.7) 
B10.A Lyt-2  ÷  B10.A  kkkd  None  0.3 (0.1) 
B6  bbbb  H-2  b  72.8 (14.3) 
B10.BR  kkkk  D  k  60.3 (12.4) 
B10.A(4R)  kkbb  D  b  23.9 (3.4) 
B10.AQR  qkkd  K  q  31.1 (6.4) 
B10.TL  skkd  K  s  29.6 (1.4) 
2  B10.A(4R) Lyt-2  ÷f  B10.A(4R)  kkbb  None  0.2 (0.0) 
B6  bbbb  K  b, LA  b  21.2 (0.4) 
B10.BR  kkkk  I-E  k, D  k  19.5 (1.0) 
B10.A(2R)  kkkb  I-E  k  0.6 (0.2) 
CBA Lyt-2  + filtered through 900  B6  bbbb  (H-2 b)  0.2 (0.0) 
rad B6 !  bml  bmlbbb  (H-2b),  K  bin1  48.7 (4.4) 
BI0.P  pppp  H-2  p  38.2 (7.7) 
* K, I-A, I-E, D. 
* Responses were measured on day 4; cells cultured in 10% FCS (Exp.  1, 3) or 0.5%  NMS (Exp. 2). 
m  Unseparated B 10.A(4R) T cells responded well to B 10.A(2R) stimulators. 
m  Normal CBA LN cells were pretreated with J1 ld +  anti-L3T4 mAb +  C' and then transferred 
intravenously into B6 mice given 900 rad irradiation 4 h before. Cells were transferred into three 
mice, each  mouse  receiving 8  ×  107  viable lymphocytes. Thoracic duct cannulation  (28)  was 
performed 16 h later and lymph-borne cells were collected between 18 and 42 h after injection; 
cells collected during this period are unresponsive to host alloantigens and are almost entirely of 
donor origin (28). The lymph-borne cells were panned on anti-Lyt-2-coated dishes (Materials and 
Methods); purified Lyt-2  + cells eluted from the dishes were then used as responders in MLR. 
to bml  also increased exponentially, but only until day 4; thereafter the response 
dropped  sharply. Addition of IL-2 to cultures of Lyt-2  + cells increased the anti- 
bml  responses  observed  between  days  2  and  4  by  about  twofold.  This  mild 
increase  in  the  B6  Lyt-2  +  anti-bml  response  caused  by  IL-2  was  offset  by  a 
dramatic  increase  in  the  background  response  with  syngeneic stimulators;  this 
applied despite prior separation of the responders  on  Percoll gradients to select 
for dense cells. 
MLR  in  the Presence of Anti-L3T4  and  Anti-Lyt-2  mAb.  Although  the  Lyt-2  ÷ 
cells used  in  the  above  experiments  contained  no  detectable  L3T4 +  cells,  the 
possibility that  the  response  of the  Lyt-2  +  cells depended  on  minimal  (<0.5%) 
contamination  with  L3T4 +  cells could  not  be  excluded.  Evidence  against  this 
possibility is shown  in Table  V.  Here  it can be seen that the MLR  of B6  Lyt-2  + 
cells to bml  stimulators was not affected by addition of anti-L3T4  mAb  to the 
cultures; by contrast,  adding anti-Lyt-2 mAb abolished the response to bml.  In SPRENT  AND  SCHAEFER  2077 
61  A  B6 L3T4  ÷  B  a6 Lyt 2 ÷ 
I 
(kill,  pan,  Percoll)  (kill,  pan,  Percoll) 
5 
bml2(~lL-2~  bml2~ 
4  B6(~*IL.2 
2  3  4  5  6  2  3  4  5  6 
Time of Assay (days) 
FmURE  3.  Effect ofadding rIL-2 (final concentration, 100U/ml) toMLRofB6L3T4+cells 
responding to a  class  II  difference (bml2) (A) vs.  B6  Lyt-2  ÷ cells responding to a  class  I 
difference (bin l) (B). All stimulator ((~)) ceils (5 x  105 viable cells per well) were pretreated 
with anti-Thy-1  mAb  +  C'.  Responder  cells were  first  placed  on  Percoll  gradients;  cells 
removed from the band 5 fraction (enriched for dense cells) were used as responders at a dose 
of 105 cells/well. Mean of triplicate cultures; cells cultured in 10% FCS. 
the case of L3T4  + responders, MLR to bml 2 stimulators were abolished by anti- 
L3T4 mAb but unaffected by anti-Lyt-2 mAb. 
An objection to the use of purified Lyt-2  ÷ cells  in the above experiments is 
that the procedures used to separate the cells might have provided an unphysi- 
ological signal  that enabled the cells to respond to antigen in the absence of 
L3T4  ÷ cells.  If so, anti-L3T4 mAb would be expected to block the response of 
unseparated T  cells to class I differences. This was not found to be the case.  As 
shown in  Table  VI,  the  response  of normal  LN cells  or  LN  T  cells to  bml 
measured on day 3 was only marginally inhibited by anti-L3T4 mAb; responses 
to bml2, by contrast, were virtually abolished by anti-L3T4 mAb.  Reciprocal 
blockage was observed with anti-Lyt-2 mAb. It may be noted that the response 
of LN or  LN T  cells to a  whole H-2  difference (B10.BR) was inhibited more 
effectively by anti-Lyt-2 than by anti-L3T4 mAb. This finding is in accordance 
with the observation that day 3-4 MLR to whole H-2 differences were generally 
higher with purified Lyt-2  ÷ than L3T4  + cells (Fig. 2; see also Table II, Exp.  1). 
Antigen-presenting  Cells for Lyt-2  + Cells.  The finding that  Lyt-2  + cells were 
not inhibited by anti-L3T4 mAb and responded to class  I  molecules across Ia 
barriers suggested that recognition of allo class  I  molecules by Lyt-2  + cells  did 
not involve co-recognition of self Ia molecules. Significantly, however, pretreat- 
ment of stimulator cells with anti-Ia mAb plus C' abolished the response of Lyt- 2078  IN  VITRO  RESPONSES  OF  PURIF1ED  T  CELL  SUBSETS 
TABLE  V 
Capacity of Anti-L3T4 vs. Anti-Lyt-2 mAb to Inhibit MLR to Class I vs. Class H H-2 
Differences: Purified T Cell Subsets as Responders 
Responders 
(1  X  l0 p) 
mAb added to MLR* 
[SH]TdR incorporation (× 10 -3) 
in response to:  ~ 
Anti-L3T4  Anti-Lyt-2  B6  bml2  bml 
B6 L3T4 + 
B6 Lyt-2  ÷ 
% 
0  0  2.5  15.1  1.6 
1  0  0.4  1.5  -- 
5  0  --  1.3  -- 
0  1  2.2  15.8  -- 
0  5  --  17.4  -- 
0  0  0.4  2.9  49.3 
1  0  0.5  0,9  54.3 
5  0  --  0.7  50.4 
0  1  0.4  0.4  1.2 
0  5  --  0.4  0.8 
* 200-#1  cultures supplemented with 2  1,1  or  10  #1  of undiluted ascites fluid 
fluid previously diluted  1  : 10 (anti-L3T4). 
* Mean of triplicate cultures; for simplicity, SD have been omitted. Cells were 
MLR measured on day 3. 
(anti-Lyt-2) or ascites 
cultured in  10%  FCS; 
TABLE  VI 
Capacity of Anti-L3T4 vs. Anti-Lyt-2 mAb to Inhibit MLR to Class I vs. Class H H-2 
Differences: Unseparated LN Cells as Responders 
[3H]TdR incorporation (× 10  -3) in response to:  0 
Responders* 
(2 x  105)  Anti-  Anti-  B6  bml  bml2  B10.BR 
L3T4  Lyt-2 
mAb added to MLR  * 
% 
Unseparated  0  0  5.3  59.6  26.6  64.4 
B6 LN  1  0  2.5  50.8  5.3  44,7 
0  1  4.4  6.8  24.9  18.4 
B6  LN  T  0  0  3.6  69.1  28.4  74.8 
1  0  1.1  64.3  4.4  54.3 
0  1  3.4  6.7  26.6  19.7 
* Responders were either untreated LN cells or LN cells pretreated with J1 ld mAb +  C' to remove 
B cells. 
See Table V. 
§ As for Table V. 
2 + cells. This is exemplified by two experiments shown in Table VII.  It can be 
seen that the response of B6 Lyt-2  ÷ cells to bm 1 stimulators was reduced to near 
background  levels by pretreating  the  stimulators  with  anti-I-A  b mAb  plus  C'; 
anti-Ia-treated  stimulators  were washed  thoroughly before culture  to prevent 
carry-over of antibody.  Adding a  source of syngeneic antigen-presenting  cells 
(APC), i.e., up to 5  ×  105 anti-Thy-1  plus C'-treated B6 spleen cells, had little 
or no effect in restoring the response. Only a slight (15-20%) restoration of the 
response occurred when the cultures were supplemented with  10%  Con A  SN SPRENT  AND  SCHAEFER  2079 
TABLE  VII 
Abolition of B6 Lyt-2  + Anti-bml MLR by Pretreatment  of Stimulators  with Anti-LA  b + C': 
Effect of Adding Syngeneic Spleen Cells or IL-2 
[SH]TdR 
Exp.  Responders  incorpora- 
No.  (1  ×  105)  *  Stimulators (pretreatment in presence of C')*  tion 
(x 1 o -s) 
1  B6 Lyt-2  +  2.5 X  105 B6  0.1 (0.0)  ~ 
5 ×  105 B6  0.5 (0.5) 
2.5 ×  105 bml  16.7 (2.3) 
5 ×  105 bml  39.9 (3.0) 
2.5 ×  105 bml (anti-l-A  b)  1.0 (0.7) 
5 X  105 bml (anti-I-A  b)  1.6 (0.5) 
2.5 X  105 bml (anti-I-A  b) +  2.5 ×  106 B6  1.4 (0.4) 
2  B6 Lyt-2  ÷  5 ×  105 B6 (anti-Thy-1)  0.3 (0.2) 
1 X  106 B6 (anti-Thy-1)  0.4 (0.3) 
2.5 X 105 bml (anti-Thy-1)  9.9 (1.0) 
5 ×  105 bml (anti-Thy-1)  19.4 (2.3) 
2.5 ×  105 bml (anti-I-A  b)  0.7 (0.3) 
5 ×  10  ~ bml (anti-I-A  b)  0.9 (0.3) 
2.5 ×  105 bml (anti-I-A  b) +  2.5 x  105 B6 (anti-Thy-1)  0.9 (0.6) 
2.5 ×  105 bml (anti-I-A  b) +  5 ×  105 B6 (anti-Thy-1)  1.1 (0.2) 
5 ×  105 bml (anti-l-A  b) +  2.5 x  105 B6 (anti-Thy-l)  1.5 (0.4) 
5 ×  105 bml (anti-I-A  b) +  5 ×  10  ~ B6 (anti-Thy-1)  2.1 (0.2) 
5 X  105 B6 (anti-Thy-1) +  10% Con A SN t  3.6 (0.5) 
5 ×  10  n B6 (anti-Thy-1) +  rIL-2  ~  4.2 (0.3) 
5 ×  105 bml (anti-Thy-l) +  10% Con A SN  34.8 (1.9) 
5 X  105 bml (anti-Thy-1) +  rIL-2  33.7 (3.2) 
5 ×  105 bml (anti-I-A  b) +  10% Con A SN  9.5 (0.7) 
5 ×  105 bml (anti-l-A  b) +  rIL-2  8.7 (0.3) 
* Lyt-2  + cells were placed on Percoll gradients; cells harvested from band 5 of the gradients were 
used as responders. 
* Spleen cells were used to prepare stimulator cells; all stimulators were exposed to 1,500 rad before 
culture. In Exp. No. 2, (B6 ×  bml)Fj rather than homozygous bml cells were used as stimulators. 
Stimulators were pretreated with either anti-Thy-1 +  C' or anti-I-A  b +  C', and washed extensively 
before culture. Numbers of stimulator cells refer to numbers of viable ceils. 
§ Mean of triplicate cultures (SD); MLR in  10% FCS measured on day 3. 
t Con A SN was supplemented with c~-methylmannoside. 
rlL-2 was added at a final concentration of 100 U/ml. 
or rlL-2  (100  U/ml)  (Table  VII);  no  further  elevation  in the  response  occurred 
when  the  dose  of rIL-2  was increased  10-fold  (data  not  shown). 
Blocking Effects of Anti-Class H  and Anti-Class I  mAb.  >10  experiments  were 
performed  to test whether  addition  of anti-la  mAb  to Lyt-2 ÷ cells in the absence 
of C'  caused  inhibition  of MLR  to class I  differences.  The  general  trend  in these 2080  IN  VITRO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
experiments was that anti-la antibodies directed to stimulator (but not responder) 
Ia determinants did cause a mild inhibition of the response to class I differences, 
but only if the control responses were relatively low. The most consistent results 
were  seen  when  responses  were  measured  in  NMS  rather  than  FCS.  A  repre- 
sentative experiment is shown in Table VIII. In this and other experiments three 
different  concentrations  of anti-Ia  mAb  were  used  to  test  for  inhibition.  For 
simplicity  the  data  obtained  with  only  one  concentration  are  shown;  higher 
concentrations of antibody often caused nonspecific inhibition. 
It can be seen from Table VIII that anti-LA b but not anti-I-A k mAb inhibited 
the response  of B6  Lyt-2 + cells to bm 1 by ~30%.  Conversely,  anti-I-A k but not 
anti-I-A b mAb  caused  a  40%  reduction  in  the  response  of  B6  Lyt-2 +  cells  to 
B10.A(4R)  (I-A k) stimulators. A  similar mild degree of inhibition occurred when 
FI  hybrid cells were used as responders,  e.g., (B6 ×  CBA)F1  cells, which express 
six Ia molecules (four I-A and two I-E molecules).  (B6 and B10.A(4R)  cells each 
express  only one  set  of Ia  (I-A)  molecules.)  In contrast  to the  modest  (though 
specific) blocking effects of anti-Ia mAb on MLR involving Lyt-2 + cells, the same 
concentrations of anti-I-A b and anti-I-A k mAb caused  marked  (80-90%)  inhibi- 
tion of the response of bm 12 L3T4 ÷ cells to B6 and B 10.A(4R) cells, respectively 
(Table VIII). 
Antibodies to class I molecules were highly effective at inhibiting responses of 
Lyt-2 + cells.  Thus, as shown in Table VIII,  Exp.  2, the response of bml  Lyt-2 + 
cells to B6 (KbD b) stimulators was almost totally abolished when anti-KbD b mAb 
was  added  to  the  cultures.  This  antibody  failed  to  inhibit  the  response  to  K k 
TABLE  VIII 
Capacity of Anti-Class H  and Anti-Class I  mAb to Block MLR of L3T4  ÷ vs. Lyt-2  ÷ T  Cells 
Exp.  Responders  mAb added to 
No.  (1  ×  10  s)  cultures* 
[SH]TdR  incorporation  (× 10  -s) against  stimulators 
(percent suppression):* 
B6  BIO.A(4R)  (B6 ×  bml2  bml  BI0.BR 
CBA)FI 
Stimulus: 
I-A  b  K k, I-A  k  LA b, H-2 k  none  -- 
bml2  L3T4 +  --  30.5  18.3  56.1  0.8  -- 
Anti-l-A b  7.1  (79%)  16.4 (11%)  36.5 (33%)  --  -- 
Anti-I-A k  29.5  (3%)  4.0 (82%)  36.3 (33%)  --  -- 
Anti-LA b +  aI-A k  --  --  21.2 (62%)  --  -- 
None  K k, I-A  k  H-2 t  I-A  b  K  lanl 
Stimulus: 
B6 Lyt-2  ÷  --  0.1  13.2  13.1  0.3  26.1  -- 
Anti-l-A  b  --  13.0 (4%)  12.2 (7%)  I  --  18.5 (29%)  -- 
Anti-I-A x  --  7.7 (43%)  9.3 (30%)  --  24.3 (7%)  -- 
Anti-LA b +  aI-A k  --  9,2 (30%)  -- 
K b  K k, I-A  k  --  --  none  H-2 x  Stimulus: 
2  bml  Lyt-2  ÷  --  40,0  69.3  --  --  0.2  47.4 
Anti-KbD ~  1.9 (96%)  67.9 (2%)  --  --  --  55,5 (0%) 
* mAb were added to the cultures in three different dilutions.  For simplicity  the results  obtained with only one concentration  are shown, the 
final concentrations of the mAb being 4% for anti-LA  b (BP 107, protein A-purified ascites  fluid), 0.16%  for anti-l-A k ( 11-5.2, unfractionated 
ascites  fluid)  and  0.2%  for anti-KbD b (20-8-4s,  protein  A-purified  ascites  fluid)  (Materials  and  Methods).  Higher concentrations  of anti- 
stimulator  anti-l-A mAb virtually  abolished the response of L3T4  + cells  but only marginally  increased  the inhibition  of the response of Lyt- 
2 + cells. 
Mean of triplicate  cultures;  for simplicity,  SD have been omitted. Cells cultured in 0.5%  NMS;  MLR  harvested on day 4. 
|  Definite inhibition  here was observed in other experiments. SPRENT  AND  SCHAEFER  2081 
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FIGURE  4.  Cytolytic activity  of B6  T  cells or  B6  Lyt-2  + cells cultured  for 4  d  with bm 1 
stimulator cells pretreated with anti-Thy-1 mAb +  C'. CTL activity was assayed over 3 h using 
51Cr-labeled Con A-stimulated blast cells as targets. Spontaneous 51Cr release from target cells 
cultured  alone  was  10-20%.  Each  point  represents  the  mean  lysis obtained  for  triplicate 
cultures; SD were within 10-1 5% of the mean. 
determinants  on B10.A(4R) cells, despite the  fact that  the anti-KbD  b mAb was 
presumably able to bind to the  D b determinants on these cells (as well as to the 
D b determinants on the bm 1 responder cells). 
CTL Generated from Purified Lyt-2  + Cells.  In all of the experiments considered 
above, the function of Lyt-2  ÷ cells was assayed by MLR, i.e., by proliferation.  In 
two experiments B6 Lyt-2  + cells were tested for their capacity to generate CTL 
against bml  stimulators (see Materials and Methods); unseparated T  cells were 
used as controls. CTL activity was measured on day 4 (the time of peak responses 
for MLR).  In both experiments,  one of which is illustrated  in  Fig.  4,  the anti- 
bm 1 CTL activities generated from these two populations were virtually indistin- 
guishable. Crossreactive lysis on bin9 target cells was low and there was no lysis 
of syngeneic targets, implying that lysis of the bm 1 targets was antigen specific. 
Stimulator  cells  were  pretreated  with  anti-Thy-1  mAb  plus  C'  to  limit  the 
possibility of exogenous IL-2 production. 
Discussion 
The main finding in this paper is that purified populations of Lyt-2  + cells give 
high  primary  MLR  and  CTL  responses  to  class  I  differences in  vitro  in  the 
apparent absence of help provided by Lyt-2- cells. The evidence that Lyt-2- Th 
cells are not required for anti-class I MLR can be summarized as follows: First, 
contamination  of the  responding  Lyt-2  + cells with  L3T4 + cells was extremely 
low, indeed undetectable by FACS analysis (Table I). Second, removal of Thy- 
1  +  cells  from  the  stimulator  population  failed  to  diminish  anti-class  I  MLR 
mediated by Lyt-2  + cells. Third, anti-class I MLR were not inhibited by addition 
of anti-L3T4 mAb to the cultures; anti-Lyt-2 mAb abolished the response. 2082  IN  VITRO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
The lack of evidence for involvement of L3T4 + cells in anti-class I MLR is in 
accordance  with  recent  studies  of von  Boehmer  et  al.  (10)  but  in  apparent 
disagreement  with the findings of Rock et al.  (18) and  Weinberger et al.  (19). 
These  latter  workers concluded that  anti-class  I  MLR reflect Ia-restricted  Th 
cell  recognition  of allo  class  I  molecules  seen  in  the  context  of self class  lI 
molecules. The main evidence for this conclusion stems from the finding of the 
authors (18,  19) that the failure of unseparated B6 T  cells to respond to anti-Ia 
plus C'-treated bm 1 stimulators could be partly overcome by adding syngeneic 
(B6) APC. Since the response was abolished by pretreating the responders with 
anti-Lyt-1  mAb plus C'  (anti-L3T4  mAb was not used), the authors concluded 
(18,  19) that the partial restoration of the response reflected antigen-processing, 
allo  class  I  molecules  being  adsorbed  by  syngeneic  APC  and  presented  in 
association with self class I1 molecules. A problem with this interpretation,  which 
the authors acknowledged, is that the responding T  cells were positive for Lyt-2 
as  well  as  Lyt-1  molecules.  The  evidence  in  the  present  paper  is  difficult  to 
reconcile with  this  hypothesis (18,  19).  First,  cell-for-cell,  purified  Lyt-2  ÷ cells 
gave higher  responses to class  I differences than  unseparated  T  cells.  Second, 
purified  L3T4 + cells gave no detectable response to class I differences. Third, 
the failure of purified Lyt-2  + cells to respond to anti-Ia plus C'-treated stimula- 
tors  could  not  be  restored  by addition  of syngeneic  APC  (Table  VII);  only 
minimal (~ 15%) restoration of the response occurred with addition of "help" in 
the  form  of IL-2.  Fourth,  anti-class  I  MLR  did  not  require  Ia  compatibility 
between the responders and stimulators, i.e., there was no apparent requirement 
for self-Ia-bearing cells. 
Recent work of Singer et al. (30) provides a partial resolution to the discrepancy 
in  the  results  mentioned  above.  This  group  maintains  that,  in  the  case of B6 
anti-bin 1 CTL, two different mechanisms govern the activation of CTL precur- 
sors.  Under normal conditions,  CTL generation  is considered to reflect "help" 
provided by Ia-independent T  cells; the authors quote unpublished data indicat- 
ing  that  these  cells  are  L3T4-  (cited  in  31).  However,  the  author~  provide 
evidence that,  under artificial conditions (presentation of antigen  by Ia + B cells 
rather than  Ia + macrophage/dendritic  cells), CTL generation can be controlled 
by Ia-restricted  L3T4 + cells.  Although  this  second  mechanism  does  not  fully 
account for the findings of Rock et al.  (18) and Weinberger et al. (19), the first 
mechanism  proposed  by Singer  et  al.  (30)  is  clearly  in  line  with  the  present 
findings.  (The  issue  of whether  the  response  of Lyt-2  + cells depends on  help 
from a helper-independent subset of Lyt-2  + cells will be considered later.) 
Although it is quite likely that  Ia-restricted  L3T4 + cells can provide help for 
Lyt-2  +  cells  under  certain  artificial  circumstances  (and  perhaps  also  in  late 
primary responses2), the point to be emphasized is that under normal conditions 
Lyt-2  + cells respond  well  to class  I  differences in  the absence  of L3T4 ÷ cells. 
This  conclusion  raises  three  questions:  (a)  Why  do  primary  MLR  to  class  I 
differences require  Ia ÷ cells?  In view of the failure to implicate  L3T4 + ceils in 
The prevailing aim in the present studies was to examine the induction phase of the response of 
Lyt-2  + cells.  For this reason CTL activity was examined early in the response, i.e., on day 4. The 
possibility that L3T4 + Th cells might amplify late (e.g., day 6) primary CTL responses has certainly 
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controlling responses to class I differences, it might seem surprising that pretreat- 
ment  of stimulator  cells  with  anti-Ia  mAb  plus  C'  abolished  the  response  of 
purified Lyt-2  + cells; other groups have made similar findings using unseparated 
T  cells as responders (18, 19, 30). Although various ad hoc models could be put 
forward to account for this paradox, perhaps the simplest explanation is that Ia  + 
cells  express  a  second  signal  required  for  the  induction  of Lyt-2  + cells  (32); 
membrane-bound  IL-1  (33) is an obvious candidate  for such a  signal.  But one 
still  has to account for the capacity of anti-Ia mAb to block anti-class I MLR in 
the absence of C'. The literature on this subject is confusing, marked inhibition 
being noted by some workers (18,  19), but not by others  (except in contrived 
situations)  (30);  unseparated  T  cells were used in  these studies.  With  purified 
Lyt-2  + cells as responders, the blocking effects of anti-Ia mAb in our hands were 
relatively mild and demonstrable only when MLR were of low magnitude (Table 
VIII).  Significantly,  inhibition  was  only  seen  with  anti-stimulator,  not  anti- 
responder mAb. Although we do not have a cogent explanation for the blocking 
effects of anti-Ia  mAb  on  anti-class  I  MLR,  our  working  hypothesis  is  that 
binding  of anti-Ia  mAb  to  Ia  determinants  on  the  stimulator  cells  somehow 
down-regulates the expression of the second signal mentioned above. Although 
such down-regulation might not be unique to anti-Ia antibodies, it is of interest 
that binding of anti-class I mAb to "bystander" stimulator determinants  (deter- 
minants not recognized by the responders) failed to cause inhibition (Table VIII). 
(b)  How does one account for the  dogma that  MLR are  directed largely  to 
class II rather than class I differences? Four points are worth making here. First, 
several groups (14,  18, 39) have observed appreciable responses to allelic class I 
differences when LN cells or purified T  cells rather than spleen cells are used as 
responders. Second, the ratio of Lyt-2  ÷ to L3T4 ÷ cells in normal T  cell popula- 
tions  is  usually  quite  low  (1:2).  Enrichment  for  Lyt-2  ÷ cells,  i.e.,  for  class  I- 
reactive  cells,  leads  to  a  substantial  increase  in  the  response  to allelic  class  I 
differences (Table IV). Third,  it is important  to emphasize that the kinetics of 
MLR to class I  vs. class II differences are very different.  In the case of L3T4 + 
cells,  the  response  to  class  II  differences  increased  exponentially  until  day  6. 
With Lyt-2  + cells, by contrast,  responses to both mutant and whole H-2 differ- 
ences peaked much  earlier,  usually at day  3-4, and  then  fell sharply  (perhaps 
reflecting destruction of the stimulator cells by newly generated CTL). The peak 
of the response was delayed slightly by using very low doses of responders, e.g., 
5  X  104, or by culturing cells in NMS, but responses were invariably very low by 
day 6. Measuring MLR only on day 5 or later can thus give the false impression 
that  class  I  differences elicit  only  weak  MLR.  When  responses are  measured 
early in the response, e.g. at day 3-4, MLR of Lyt-2  ÷ cells to class I differences 
are often higher than L3T4 + anti-class II MLR. A final point worth mentioning 
is that the conclusion that Lyt-2  + cells give high  MLR to class I differences rests 
on studies with mice of the B6 and B10 backgrounds. Interestingly, preliminary 
studies  have  shown  that  MLR  of  Lyt-2  ÷  cells  to  whole  H-2  differences  are 
appreciably  lower  with  CBA/Ca  and  DBA/2  cells  than  with  B6  cells.  The 
significance of this apparent strain variation is unclear. 
(c)  Are  all  unprimed  Lyt-2  + cells helper  independent?  Some  Lyt-2  ÷ T  cell 
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specific antigen in the absence of exogenous IL-2 (8-10, 35). In some instances 
these clones synthesize their own IL-2 (35, 36); other clones are helper dependent 
(HD), i.e.,  require exogenous IL-2.  Since T  cell clones can change from being 
HI to HD in vitro (10), it is conceivable that all unprimed Lyt-2  ÷ cells are initially 
HI cells but then gradually become HD as the cells differentiate (10). Thus, Lyt- 
2 + cells might  initially produce their  own help (IL-2) but then  tend to become 
dependent on help provided by other cells, either L3T4 + cells or HI Lyt-2  + cells. 
According to this  notion,  in contrast to secondary responses one might  expect 
primary responses of Lyt-2  + cells to be relatively independent of exogenous help. 
The  evidence  that  unprimed  Lyt-2  +  cells  can  cause  lethal  GVHD  to  minor 
histocompatibility antigens in irradiated  mice (12) and give high primary  MLR 
and CTL responses to allo class I differences (this paper) is certainly consistent 
with this possibility. 
It does not necessarily follow that all primary responses of Lyt-2  ÷ cells are HI. 
In this respect Singer (personal communication) has found that although gener- 
ation of primary CTL responses to most mutant class I differences are HI, the 
response of B6 T  cells to the bin6  mutant  is heavily dependent on exogenous 
help from L3T4 + cells. Likewise, exogenous helper cells seem to be required for 
priming  Lyt-2  +  CTL  specific  for  the  H-Y  antigen  (37).  These  "exceptions," 
however, might simply reflect a very low precursor frequency of the responder 
cells: the latter might be HI initially but be incapable of expansion to detectable 
levels without  help  from  other  cells.  This  explanation  cannot  account for the 
data  on  the  response  to the  bin6  mutant,  however,  since  the  CTL  precursor 
frequency for B6 anti-bin6  responses is reported to be almost as high as for B6 
anti-bml  responses (38). Although we have not studied CTL responses to bm6, 
it is of interest that  MLR of B6 Lyt-2  + cells to the apparently identical mutant, 
bm9, are far lower than to the other mutants studied (Table III). In the light of 
these findings, it is quite possible that unprimed Lyt-2  ÷ cells comprise a mixture 
of HI and HD cells, the ratio of HI to HD cells being high for responses to bml 
(also bm4 and bml 1, Table III) but low for bm9 (and perhaps antigens such as 
H-Y).  Although  unprimed  HD Lyt-2  + cells could represent a  separate  lineage, 
HD cells might arise from HI cells in vivo as the result of repeated contact with 
cross reactive environmental antigens. 
As a  final comment on "help," it should be noted that although  we favor the 
notion that most cells participating in B6 anti-bm 1 responses are HI cells, direct 
evidence on this point is lacking. Thus, on a priori grounds one could argue that 
the majority of the Lyt-2  + cells participating  in primary B6 anti-bml  responses 
are  HD  cells,  the  differentiation  of these  cells  being  controlled  by a  minor 
population of IL-2-producing H1 Lyt-2  ÷ cells. Limiting dilution analysis will  be 
needed to assess this possibility. 
One of the main aims in this paper was to assess the stringency of the role of 
T  cell accessory molecules in  controlling  recognition  of H-2 molecules.  It  has 
been  suggested  by other  workers  (39)  that  Lyt-2 and  L3T4  molecules play a 
highly selective role in guiding T  cell recognition of class I and class II molecules, 
respectively.  The  present  data are  in  close agreement  with  this  notion.  Thus, 
purified  Lyt-2+ cells responded only to allo class I and  not class II differences 
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that  although  responses  of purified  Lyt-2  ÷  cells  to  class  II  differences  were 
generally undetectable, very low responses were occasionally seen. Interestingly, 
these marginal  responses could be inhibited either by anti-L3T4  or anti-Lyt-2 
mAb (Table V).  One explanation  for this  finding  is that  some Lyt-2  ÷ cells do 
have class II reactivity (see 40) but,  unlike class I-reactive cells, these class II- 
restricted  Lyt-2  + cells are  heavily dependent  on  help  from  L3T4 + cells;  very 
minor contamination of the cultures with L3T4 + cells could thus allow these HD 
Lyt-2  + cells to expand.  In support of this possibility we have found (unpublished 
data) that bulk cultures of unseparated B6 T  cells stimulated against bm 12 cells 
contain  quite a  high  proportion  (30%) of Lyt-2  + blasts.  Whether  these  Lyt-2  + 
blasts are specific by bml2  or are  stimulated  nonspecifically is unclear.  In the 
reciprocal  situation,  stimulation  of unseparated  B6 T  cells with bm 1 cells gen- 
erates only Lyt-2  ÷ and not L3T4 + blasts (unpublished data). 
The data in this paper are concerned solely with primary responses measured 
in vitro.  In a  subsequent paper we shall  demonstrate  that  purified Lyt-2  + cells 
respond well to allo class I molecules in vivo by a number of parameters, including 
proliferation, GVHD, and skin graft rejection. 
Summary 
In  light of the widely accepted view that  Ia-restricted  L3T4 + T  helper cells 
play a decisive role in controlling the differentiation of Lyt-2  + cells, experiments 
were designed  to examine  whether  Lyt-2  + cells can  respond  to antigen  in  the 
absence of L3T4 + cells. The results showed that highly purified Lyt-2  + cells gave 
high primary mixed lymphocyte reactions (MLR) to various class I differences, 
including both mutant and allelic differences; responses to class II (Ia) differences 
were generally undetectable with Lyt-2  ÷ cells. The intensity of MLR to class I 
differences was not  affected by addition  of anti-L3T4  monoclonal  antibodies 
(mAb) to the cultures or by removing T  cells from the stimulator populations. 
Negative selection experiments showed that Lyt-2  + cells could respond to class I 
differences across Ia barriers.  MLR of purified Lyt-2  ÷ cells peaked on days 3-4 
and  then  fell sharply;  background  responses with  syngeneic  stimulators  (auto- 
MLR)  were  virtually  absent.  Parallel  experiments  with  purified  L3T4 ÷  ceils 
showed that this subset (a) responded in MLR only to class II (Ia) and not class 
I  differences, (b) reached peak responses only on day 6  rather  than  days 3-4, 
and (c) often gave high auto-MLR. Within the first 3-4 d of culture, MLR were 
generally higher with Lyt-2  + cells than L3T4 + cells. 
Although  no  evidence  could  be  found  that  Ia-restricted  L3T4 + cells were 
required  for  the  response  of Lyt-2  + cells,  presentation  of antigen  by Ia  + cells 
appeared to be essential. Thus, responses were ablated by pretreating stimulator 
cells with anti-Ia mAb plus C'. Significantly the failure of Lyt-2  + cells to respond 
to anti-Ia plus C'-treated stimulators could not be restored by adding syngeneic 
spleen  cells;  addition  of IL-2  led  to  only  a  minor  (15%)  restoration  of the 
response.  It  is  suggested  that  Ia +  cells  provide  an  obligatory  second  signal 
required by Lyt-2  + cells. 2086  IN  VITRO  RESPONSES OF  PURIFIED T  CELL  SUBSETS 
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